BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, February 4, 2026
Home » Blogs » BioWorld MedTech Perspectives » FCC holds MBANs future in its hands

BioWorld MedTech Perspectives
BioWorld MedTech Perspectives RSS FeedRSS

Medical technology

FCC holds MBANs future in its hands

May 29, 2012
By Omar Ford

A patient lies tethered to a hospital bed with sensors and wires taking readings. Their mobility is severely limited and, on top of that, healthcare professionals have to be in a position where they can maneuver through these wires to treat the patient. This is a scenario that plays out in many hospitals throughout the country.

But that could change if the Federal Communications Commission (FCC) approves a measure that would expand the spectrum capacity for Medical Body Area Networks (MBAN), or wireless patient monitoring systems that use low-cost wearable sensors and allow clinicians to remotely monitor vital signs of patients. If the spectrum is increased, then this would give companies like GE and Philips Healthcare the greenlight to work on a variety of MBAN devices.

Some industry insiders have told Medical Device Daily that they expect the FCC will approve this measure, even Julius Genachowski FCC chairman indicated that he thought agency would vote in favor of expanding the MBAN frequency.

When this happens, the confusing ball of wires that we see patients trapped underneath probably won’t immediately go away, but in time we’ll start to see a transition. With that transition we will see more ease of use, less clutter in hospitals and better service.

As these changes occur, members of the med-tech industry said healthcare professionals will be able to identify patients earlier, whose conditions are deteriorating, and intervene in a more timely fashion. As these sensors become available they can become embedded in homes and long-term care facilities, which will give unprecedented monitoring for patients.

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Feb. 4, 2025.
  • Today's news in brief

    Briefs
    BioWorld MedTech briefs for Jan. 30, 2026.
  • Illustration of brain with neuron receptor

    5-HT2R allosteric ligands attenuate cocaine use and seeking behavior

    BioWorld Science
    Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...
  • Art concept for medical research

    MicroRNAs in circulating extracellular vesicles as IPF biomarkers

    BioWorld Science
    MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
  • Brain illustration

    MJFF grant supports Bexorg’s translational biomarker work

    BioWorld Science
    Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing